Tsubota Laboratory Incorporated

2026/08/12 Updated
Market Cap: $44.4M (¥7.1B)
Stock Price: $1.72 (¥274)
Exchange Rate: 1 USD = ¥159.24

First Quarter Financial Summary for the Fiscal Year Ending March 2027 (Japanese GAAP) (Consolidated)

Revenue was 215,410 thousand yen, a substantial increase YoY. Operating loss was 170,632 thousand yen, ordinary loss 133,859 thousand yen, and quarterly net loss 134,154 thousand yen. The full-year outlook remains unchanged at 1,100 million yen to 1,500 million yen in revenue and profit. R&D investment and licensing revenue timing are likely to cause quarterly fluctuations.

Importance:
Page Updated: August 12, 2026
IR Disclosure Date: August 12, 2026

Key Figures

  • Revenue: 215,409 thousand yen
  • Operating loss: △170,632 thousand yen
  • Quarterly net loss: △134,154 thousand yen

AI要約

Overview of results

This quarter saw a substantial year-on-year increase in revenue due to recognizing milestone revenue from license agreements. However, continuing research and development and business development led to operating loss, ordinary loss, and net loss. Progress in R&D investments and the contractual structure mean the timing of revenue recognition can significantly affect results quarter by quarter.

Outlook and financial position

The full-year forecast remains unchanged from the disclosure. On a quarterly basis, revenue depends on the timing of contract closures, so the impact on the full-year remains limited. Cash and deposits amount to 699,259 thousand yen, total assets 1,312,401 thousand yen, and equity ratio 55.6%, indicating sufficient funds to sustain operations for one year.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Tsubota Lab Incorporated

Company overview · Stock price · Financial data · All IR

View company page →